# A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects

> **NCT00656097** · PHASE2 · COMPLETED · sponsor: **Crucell Holland BV** · enrollment: 140 (actual)

## Conditions studied

- Rabies

## Interventions

- **BIOLOGICAL:** CL184
- **BIOLOGICAL:** HRIG
- **BIOLOGICAL:** Placebo matching CL184

## Key facts

- **NCT ID:** NCT00656097
- **Lead sponsor:** Crucell Holland BV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2011-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00656097

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00656097, "A Randomized Phase II Trial to Compare the Safety and Neutralizing Activity of CL184 in Combination With Rabies Vaccine vs. HRIG or Placebo in Combination With Rabies Vaccine in Healthy Adult Subjects". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT00656097. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*